ScinoPharm Taiwan, Ltd.

TWSE:1789.TW

23 (TWD) • At close November 14, 2024
Bedrijfsnaam ScinoPharm Taiwan, Ltd.
Symbool 1789.TW
Munteenheid TWD
Prijs 23
Beurswaarde 18,186,997,000
Dividendpercentage 1.29%
52-weken bereik 23 - 30.5
Industrie Drug Manufacturers—Specialty & Generic
Sector Healthcare
CEO Ms. Li-An Lu
Website https://www.scinopharm.com

An error occurred while fetching data.

Over ScinoPharm Taiwan, Ltd.

ScinoPharm Taiwan, Ltd., together with its subsidiaries, researches and develops, produces, and sells cGMP active pharmaceutical ingredients (API) to pharmaceutical companies in Taiwan, the United States, Europe, India, rest of Asia, and internationally. The company offers custom synthesis services for biochemistry molecules, such as peptides and nucleic acids; generic API

Vergelijkbare Aandelen

Tanvex BioPharma, Inc. logo

Tanvex BioPharma, Inc.

6541.TW

63.3 TWD

Grape King Bio Ltd logo

Grape King Bio Ltd

1707.TW

151 TWD

Adimmune Corporation logo

Adimmune Corporation

4142.TW

22 TWD

YungShin Global Holding Corporation logo

YungShin Global Holding Corporation

3705.TW

53.5 TWD

Excelsior Medical Co., Ltd. logo

Excelsior Medical Co., Ltd.

4104.TW

86.3 TWD

Pegavision Corporation logo

Pegavision Corporation

6491.TW

369 TWD

Panion & Bf Biotech Inc. logo

Panion & Bf Biotech Inc.

1760.TW

90.6 TWD

SCI Pharmtech, Inc. logo

SCI Pharmtech, Inc.

4119.TW

94.9 TWD

Standard Chem & Pharm CO., LTD. logo

Standard Chem & Pharm CO., LTD.

1720.TW

63.3 TWD

China Chemical & Pharmaceutical Co., Ltd. logo

China Chemical & Pharmaceutical Co., Ltd.

1701.TW

21.15 TWD

Financiële Gegevens

Cijfers zijn in miljoenen (TWD)

Cijfers zijn in miljoenen (TWD)